234 related articles for article (PubMed ID: 35747866)
1. ENDOCRINE DISRUPTING CHEMICALS AND OBESITY: THE EVOLVING STORY OF OBESOGENS.
Micić D; Polovina S; Micić D; Macut D
Acta Endocrinol (Buchar); 2021; 17(4):503-508. PubMed ID: 35747866
[TBL] [Abstract][Full Text] [Related]
2. Environmental Obesogens: Mechanisms and Controversies.
Heindel JJ; Blumberg B
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():89-106. PubMed ID: 30044726
[TBL] [Abstract][Full Text] [Related]
3. Obesogens: an emerging threat to public health.
Janesick AS; Blumberg B
Am J Obstet Gynecol; 2016 May; 214(5):559-65. PubMed ID: 26829510
[TBL] [Abstract][Full Text] [Related]
4. Role of Obesogens in the Pathogenesis of Obesity.
Shahnazaryan U; Wójcik M; Bednarczuk T; Kuryłowicz A
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438630
[TBL] [Abstract][Full Text] [Related]
5. Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action.
Mohajer N; Du CY; Checkcinco C; Blumberg B
Front Endocrinol (Lausanne); 2021; 12():780888. PubMed ID: 34899613
[TBL] [Abstract][Full Text] [Related]
6. The new kids on the block: Emerging obesogens.
Chamorro-Garcia R; Veiga-Lopez A
Adv Pharmacol; 2021; 92():457-484. PubMed ID: 34452694
[TBL] [Abstract][Full Text] [Related]
7. Obesogens in Foods.
Kladnicka I; Bludovska M; Plavinova I; Muller L; Mullerova D
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625608
[TBL] [Abstract][Full Text] [Related]
8. Obesogens and Obesity: State-of-the-Science and Future Directions Summary from a Healthy Environment and Endocrine Disruptors Strategies Workshop.
Heindel JJ; Alvarez JA; Atlas E; Cave MC; Chatzi VL; Collier D; Corkey B; Fischer D; Goran MI; Howard S; Kahan S; Kayhoe M; Koliwad S; Kotz CM; La Merrill M; Lobstein T; Lumeng C; Ludwig DS; Lustig RH; Myers P; Nadal A; Trasande L; Redman LM; Rodeheffer MS; Sargis RM; Stephens JM; Ziegler TR; Blumberg B
Am J Clin Nutr; 2023 Jul; 118(1):329-337. PubMed ID: 37230178
[TBL] [Abstract][Full Text] [Related]
9. Obesogens, stem cells and the maternal programming of obesity.
Blumberg B
J Dev Orig Health Dis; 2011 Feb; 2(1):3-8. PubMed ID: 26401242
[TBL] [Abstract][Full Text] [Related]
10. Obesogens in Adolescence: Challenging Aspects and Prevention Strategies.
Nicolaou M; Toumba M; Kythreotis A; Daher H; Skordis N
Children (Basel); 2024 May; 11(5):. PubMed ID: 38790597
[TBL] [Abstract][Full Text] [Related]
11. Obesity and endocrine-disrupting chemicals.
Amato AA; Wheeler HB; Blumberg B
Endocr Connect; 2021 Feb; 10(2):R87-R105. PubMed ID: 33449914
[TBL] [Abstract][Full Text] [Related]
12. Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants-A Review.
Kowalczyk M; Piwowarski JP; Wardaszka A; Średnicka P; Wójcicki M; Juszczuk-Kubiak E
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674599
[TBL] [Abstract][Full Text] [Related]
13. Obesity II: Establishing causal links between chemical exposures and obesity.
Heindel JJ; Howard S; Agay-Shay K; Arrebola JP; Audouze K; Babin PJ; Barouki R; Bansal A; Blanc E; Cave MC; Chatterjee S; Chevalier N; Choudhury M; Collier D; Connolly L; Coumoul X; Garruti G; Gilbertson M; Hoepner LA; Holloway AC; Howell G; Kassotis CD; Kay MK; Kim MJ; Lagadic-Gossmann D; Langouet S; Legrand A; Li Z; Le Mentec H; Lind L; Monica Lind P; Lustig RH; Martin-Chouly C; Munic Kos V; Podechard N; Roepke TA; Sargis RM; Starling A; Tomlinson CR; Touma C; Vondracek J; Vom Saal F; Blumberg B
Biochem Pharmacol; 2022 May; 199():115015. PubMed ID: 35395240
[TBL] [Abstract][Full Text] [Related]
14. Inherited Epigenetic Hallmarks of Childhood Obesity Derived from Prenatal Exposure to Obesogens.
Núñez-Sánchez MÁ; Jiménez-Méndez A; Suárez-Cortés M; Martínez-Sánchez MA; Sánchez-Solís M; Blanco-Carnero JE; Ruiz-Alcaraz AJ; Ramos-Molina B
Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981620
[TBL] [Abstract][Full Text] [Related]
15. Environmental Obesogens and Their Impact on Susceptibility to Obesity: New Mechanisms and Chemicals.
Egusquiza RJ; Blumberg B
Endocrinology; 2020 Mar; 161(3):. PubMed ID: 32067051
[TBL] [Abstract][Full Text] [Related]
16. Is Technical-Grade Chlordane an Obesogen?
Silva JF; Moreira BP; Rato L; de Lourdes Pereira M; Oliveira PF; Alves MG
Curr Med Chem; 2021; 28(3):548-568. PubMed ID: 31965937
[TBL] [Abstract][Full Text] [Related]
17. Endocrine Disruptors and Obesity.
Darbre PD
Curr Obes Rep; 2017 Mar; 6(1):18-27. PubMed ID: 28205155
[TBL] [Abstract][Full Text] [Related]
18. Obesogens, stem cells and the developmental programming of obesity.
Janesick A; Blumberg B
Int J Androl; 2012 Jun; 35(3):437-48. PubMed ID: 22372658
[TBL] [Abstract][Full Text] [Related]
19. Transgenerational effects of obesogens.
Lee MK; Blumberg B
Basic Clin Pharmacol Toxicol; 2019 Aug; 125 Suppl 3(Suppl 3):44-57. PubMed ID: 30801972
[TBL] [Abstract][Full Text] [Related]
20. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity.
Janesick A; Blumberg B
Birth Defects Res C Embryo Today; 2011 Mar; 93(1):34-50. PubMed ID: 21425440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
